MAQ GTTE VENUS BREEZE 2EN1 LIDAMIDINA CLORHIDRATO DE Ixekizumab 80 mg/mL

Description

Ixekizumab 80 mg/mL

FORMA FARMACÉUTICA: 12 COMPRIMIDOS

FORMA FARMACÉUTICA: 5 SOLUCION INYECTABLE AMPULA

Aplicar al menos 24 horas después de la quimioterapia

Reacciones locales en el sitio de aplicación

MAQ GTTE VENUS BREEZE 2EN1 LIDAMIDINA CLORHIDRATO DE Ixekizumab 80 mg/mL1 Pieza Caja

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy